Staffan Schüberg
Director/Board Member at SWEDISH ORPHAN BIOVITRUM AB
Net worth: 167 703 $ as of 2024-03-30
Profile
Staffan Schüberg is currently the Chief Executive Officer at Corporación Químico Farmaceútica Esteve SA, Esteve Pharmaceuticals S.A., and Esteve Healthcare SL.
He is also a Director at Dizlin Medical Design AB, Dizlin Pharmaceuticals AB, and Pensa Investments SL, as well as an Independent Director at Swedish Orphan Biovitrum AB.
In the past, he served as Chairman & President at Lundbeck, Inc. (Illinois), President & Director at Chelsea Therapeutics International Ltd., Managing Director at Lundbeck Portugal Produtos Farmaceuticos Unipessoal Ltda., Chief Commercial Officer & Executive VP at H.
Lundbeck A, and President at Lundbeck USA Inc. He also served as a Director at Hangzhou Jiuyuan Gene Engineering Co. Ltd.
Mr. Schüberg received his undergraduate degree from London Guildhall University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-09-11 | 6,711 ( 0.00% ) | 167 703 $ | 2024-03-30 |
Staffan Schüberg active positions
| Companies | Position | Start |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Director/Board Member | 2019-12-31 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | 2010-12-21 |
Dizlin Medical Design AB
 Dizlin Medical Design AB Pharmaceuticals: MajorHealth Technology Dizlin Medical Design AB manufactures pharmaceutical products. The private company is based in Vimmerby, Sweden. | Director/Board Member | - |
Esteve Pharmaceuticals S.A.
 Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Chief Executive Officer | - |
Pensa Investments SL
 Pensa Investments SL Miscellaneous Commercial ServicesCommercial Services Pensa Investments SL engages in the manufacture of pharmaceutical facilities. The firm specializes in the research, production, development, storage, lease, commercialization, and sale of raw materials and property. The company was founded on December 20, 2019 and is headquartered in Martorelles, Spain. | Director/Board Member | 2020-01-23 |
Corporación Químico Farmaceútica Esteve SA
 Corporación Químico Farmaceútica Esteve SA Pharmaceuticals: MajorHealth Technology Corporación QuÃmico Farmacéutica Esteve SA is a pharmaceutical company based in Barcelona, ES. and has subsidiaries in the Europe and Americas regions. Esteve manufactures and distributes pharmaceutical products. The Spanish company was founded in 1986 and the CEO is Staffan Schüberg. | Chief Executive Officer | - |
| Dizlin Pharmaceuticals AB | Director/Board Member | - |
Esteve Healthcare SL
 Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019. | Chief Executive Officer | 2018-12-31 |
Former positions of Staffan Schüberg
| Companies | Position | End |
|---|---|---|
| H. LUNDBECK A/S | Corporate Officer/Principal | 2017-10-30 |
| ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Training of Staffan Schüberg
| London Guildhall University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private companies | 12 |
|---|---|
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
| Lundbeck, Inc. (Illinois) | |
| Lundbeck USA Inc. | |
Corporación Químico Farmaceútica Esteve SA
Corporación Químico Farmaceútica Esteve SA Pharmaceuticals: MajorHealth Technology Corporación QuÃmico Farmacéutica Esteve SA is a pharmaceutical company based in Barcelona, ES. and has subsidiaries in the Europe and Americas regions. Esteve manufactures and distributes pharmaceutical products. The Spanish company was founded in 1986 and the CEO is Staffan Schüberg. | Health Technology |
Hangzhou Jiuyuan Gene Engineering Co. Ltd.
 Hangzhou Jiuyuan Gene Engineering Co. Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Jiuyuan Gene Engineering Co. Ltd. operates as a biopharmaceutical company. It specializes in R&D, manufacturing and commercialization of biopharmaceutical products and medical devices. Hangzhou Jiuyuan therapeutic includes orthopedics, metabolic diseases, oncology, and hematology services. The company was founded on December 31, 1993 and is headquartered in Hangzhou, China. | Health Technology |
Dizlin Medical Design AB
Dizlin Medical Design AB Pharmaceuticals: MajorHealth Technology Dizlin Medical Design AB manufactures pharmaceutical products. The private company is based in Vimmerby, Sweden. | Health Technology |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
| Dizlin Pharmaceuticals AB | |
Pensa Investments SL
Pensa Investments SL Miscellaneous Commercial ServicesCommercial Services Pensa Investments SL engages in the manufacture of pharmaceutical facilities. The firm specializes in the research, production, development, storage, lease, commercialization, and sale of raw materials and property. The company was founded on December 20, 2019 and is headquartered in Martorelles, Spain. | Commercial Services |
Esteve Healthcare SL
Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019. | Health Technology |
| Lundbeck Portugal Produtos Farmaceuticos Unipessoal Ltda. |
- Stock Market
- Insiders
- Staffan Schüberg
